Osteoprotegerin/TNFRSF11B Antibody [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # AF459H

Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Immunohistochemistry, Neutralization
Label
HRP
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse Osteoprotegerin/TNFRSF11B
Glu22-Leu401 with a Gln138Arg substitution
Accession # Q6PI12
Glu22-Leu401 with a Gln138Arg substitution
Accession # Q6PI12
Specificity
Detects mouse Osteoprotegerin in direct ELISAs and Western blots. In direct ELISAs, approximately 40% cross-reactivity with recombinant human Osteoprotegerin is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Osteoprotegerin/TNFRSF11B Antibody [HRP]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Osteoprotegerin/TNFRSF11B
Alternate Names
OCIF, TNFRSF11B
Gene Symbol
TNFRSF11B
Additional Osteoprotegerin/TNFRSF11B Products
Product Documents for Osteoprotegerin/TNFRSF11B Antibody [HRP]
Product Specific Notices for Osteoprotegerin/TNFRSF11B Antibody [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...